New pill Q702 aims to outsmart blood cancers in early trial
NCT ID NCT06712810
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage trial is testing a new drug called Q702 in people with various blood cancers and related disorders that have not responded to standard treatments. Q702 is designed to help the immune system attack cancer cells and help the bone marrow make healthy blood cells. The study will enroll 46 participants to find the safest dose and see if the drug can shrink tumors or control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Q702 (a pill that helps the immune system kill cancer cells and supports normal blood cell production)
- What this could lead to
- If it works, this could point toward a new treatment option for people with certain blood cancers or histiocytic disorders who have run out of standard therapies.
- What could go wrong
- This is a very early (Phase I) trial with only 46 participants, so it is primarily testing safety and dosing. It may not show strong anti-cancer effects, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone app may help young cancer survivors get fitter — a trial puts it to the test
- Faith and mindfulness join forces to heal black cancer survivors
- New antibody combo aims to treat brain lymphoma
- Sniffing away sickness: essential oils tested for chemo nausea
- Could a cancer drug shrink recurrent brain tumors?
- AI could speed up radiation planning by automatically mapping healthy tissues